Artículos con órdenes de acceso público - Yusuf DeeniMás información
Disponibles en algún lugar: 7
Quantitative analysis of NRF2 pathway reveals key elements of the regulatory circuits underlying antioxidant response and proliferation of ovarian cancer cells
HS Khalil, A Goltsov, SP Langdon, DJ Harrison, J Bown, Y Deeni
Journal of biotechnology 202, 12-30, 2015
Órdenes: Breast Cancer Now, UK
A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells
HS Khalil, SP Langdon, A Goltsov, T Soininen, DJ Harrison, J Bown, ...
Oncotarget 7 (46), 75874, 2016
Órdenes: Breast Cancer Now, UK
NRF2 regulates HER1 signaling pathway to modulate the sensitivity of ovarian cancer cells to lapatinib and erlotinib
IH Kankia, HS Khalil, SP Langdon, PR Moult, JL Bown, YY Deeni
Oxidative Medicine and Cellular Longevity 2017 (1), 1864578, 2017
Órdenes: Breast Cancer Now, UK
Cytochrome P450 CYP1B1 Interacts with 8-Methoxypsoralen (8-MOP) and Influences Psoralen-Ultraviolet A (PUVA) Sensitivity
YY Deeni, SH Ibbotson, JA Woods, CR Wolf, G Smith
PLoS One 8 (9), e75494, 2013
Órdenes: Cancer Research UK, UK Medical Research Council
COVID-19 mortality rate and its associated factors during the first and second waves in Nigeria
K Elimian, A Musah, C King, E Igumbor, P Myles, O Aderinola, C Erameh, ...
PLOS global public health 2 (6), e0000169, 2022
Órdenes: National Institute for Health Research, UK
Nuclear factor erythroid 2-related factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors
IH Kankia, P Paramasivan, M Elcombe, SP Langdon, YY Deeni
Exploration of targeted anti-tumor therapy 2 (2), 187, 2021
Órdenes: Breast Cancer Now, UK
Nuclear Factor Erythroid Factor 2 modulates HER4 receptor in ovarian cancer cells to influence their sensitivity to tyrosine kinase inhibitors
IH Kankia, P Paramasivan, M Elcombe, SP Langdon, Y Deeni
Exploration of Targeted Anti-tumor Therapy, 2021
Órdenes: Breast Cancer Now, UK
La información de publicación y financiación se determina de forma automática mediante un programa informático